Search research articles
Contact Us
Filters
Showing results (151-160 of 283) with videos related to
Page
of 29
Sort By:
International Journal of Molecular Sciences
|
July 26, 2020
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
Panagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, et al.
European Journal of Clinical Investigation
|
July 30, 2020
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis
Stefano Figliozzi, Pier Giorgio Masci, Navid Ahmadi, et al.
Oncotarget
|
January 18, 2019
Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study
Despoina Kalapanida, Flora Zagouri, Maria Gazouli, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 4, 2026
Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell Therapy
Alexandros Briasoulis, Niki Lama, Angelos Soranidis, et al.
Atherosclerosis
|
December 8, 2009
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study
Ioannis Andreou, Dimitris Tousoulis, Antigoni Miliou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2018
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis
Meletios Athanasios Dimopoulos, Jonathan L Kaufman, Darrell White, et al.
BMC Cancer
|
May 20, 2021
Germline mutations in a clinic-based series of pregnancy associated breast cancer patients
Eleni Zografos, Anna-Maria Korakiti, Angeliki Andrikopoulou, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 13, 2024
Chemotherapy response score as a predictor of survival in ovarian cancer patients
Ioannis Rodolakis, Michalis Liontos, Vasilios Pergialiotis, et al.
Cancers
|
July 14, 2023
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
Angeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
Michalis Liontos, Anna Svarna, Charalampos Theofanakis, et al.
Page
of 29
Search research articles
Search
Showing results (151-160 of 283) with videos related to
Sort By:
Page
of 29
International Journal of Molecular Sciences
|
July 26, 2020
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
Panagiotis Efentakis, Hendrik Doerschmann, Claudius Witzler, et al.
European Journal of Clinical Investigation
|
July 30, 2020
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis
Stefano Figliozzi, Pier Giorgio Masci, Navid Ahmadi, et al.
Oncotarget
|
January 18, 2019
Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study
Despoina Kalapanida, Flora Zagouri, Maria Gazouli, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 4, 2026
Improvement in Cardiac Magnetic Resonance Parameters in Patients With Cardiac Light-Chain Amyloidosis Receiving Anticlonal Cell Therapy
Alexandros Briasoulis, Niki Lama, Angelos Soranidis, et al.
Atherosclerosis
|
December 8, 2009
Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study
Ioannis Andreou, Dimitris Tousoulis, Antigoni Miliou, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2018
A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis
Meletios Athanasios Dimopoulos, Jonathan L Kaufman, Darrell White, et al.
BMC Cancer
|
May 20, 2021
Germline mutations in a clinic-based series of pregnancy associated breast cancer patients
Eleni Zografos, Anna-Maria Korakiti, Angeliki Andrikopoulou, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 13, 2024
Chemotherapy response score as a predictor of survival in ovarian cancer patients
Ioannis Rodolakis, Michalis Liontos, Vasilios Pergialiotis, et al.
Cancers
|
July 14, 2023
Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer
Angeliki Andrikopoulou, Charalampos Theofanakis, Christos Markellos, et al.
Current Oncology (Toronto, Ont.)
|
December 13, 2021
What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience
Michalis Liontos, Anna Svarna, Charalampos Theofanakis, et al.
Page
of 29